AstraZeneca's (AZN) Fasenra sBLA for Nasal Polyps Gets CRL
Zacks via Yahoo Finance· 2 months agoAstraZeneca AZN announced that the FDA has issued a complete response letter to its supplemental...
AstraZeneca's Fasenra Meets Endpoint in Rhinosinusitis Study
Zacks via Yahoo Finance· 2 years agoAstraZeneca AZN announced that the phase III OSTRO study evaluating its asthma drug, Fasenra...
AstraZeneca’s Asthma Drug Fasenra Meets Late-Stage Targets; Shares Rise
SmarterAnalyst via Yahoo Finance· 2 years agoAstraZeneca announced on Thursday that its Fasenra asthma therapy used in the treatment for a...
New Five-Year Data Shows Durable Efficacy Of AstraZeneca's Fasenra For Asthma Treatment
Benzinga via Yahoo Finance· 1 year agoAstraZeneca Plc (NASDAQ: AZN) has announced results from a new integrated analysis, including data...
AstraZeneca's asthma drug succeeds late-stage study
Reuters via Yahoo Finance· 2 years agoThe treatment, Fasenra, showed a statistically significant improvement in treating patients with severe bilateral nasal polyposis that were still...
FDA Declines To Approve AstraZeneca's Asthma Treatment For Chronic Nasal Condition
Benzinga via Yahoo Finance· 2 months agoThe FDA has declined to approve AstraZeneca Plc's (NASDAQ: AZN) asthma medicine, Fasenra...
2 Deeply Discounted Dividend Stocks to Buy and Hold Right Now
Motley Fool· 12 months agoAstraZeneca's new drugs are one reason for optimism about its growth. The global asthma market in...
Pharma Stock Roundup: AZN & PFE's Coronavirus Vaccine Updates & FDA Approvals
Zacks via Yahoo Finance· 2 years agoAstraZeneca said the review by the independent data committee is a standard procedure when there is...
AstraZeneca-Amgen drug could widen treatment options for severe asthma
Reuters via Yahoo Finance· 1 year agoAstraZeneca and Amgen's experimental drug reduced asthma attacks in patients with severe and...
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 7 months agoAstraZeneca AZN will report third-quarter 2021 results on Nov 12, before market open. The company...